Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Necrobotics is a field of engineering that builds robots out of a mix of synthetic materials and animal body parts. It has produced micro-grippers with pneumatically operated legs taken from dead ...

Washington — President Trump said Friday he is canceling all orders signed by former President Joe Biden using an autopen, a mechanical device that reproduces signatures. "Any document signed" by ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

A severed mosquito proboscis can be turned into an extremely fine nozzle for 3D printing, and this could help create replacement tissues and organs for transplants. Changhong Cao at McGill University ...

Apple has highlighted its use of 3D printing to make Apple Watch cases, to cut material use — and to enable a new, thin USB-C port for the iPhone Air. Most of the time, 3D printing is now associated ...

Winter is here! The air is crisper and colder, and the days are shorter. My neighbor, whom I usually see on the front porch every morning, disappears into the comforts of his home for the season. It ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Construction robots are no longer a far-off idea. They're already changing job sites by tackling repetitive, heavy, and often dangerous tasks. The latest robot comes from Australia, where a ...